- Home
- SGU vs FLGT Comparison
SGU vs FLGT Comparison
Compare SGU & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGU
- FLGT
- Stock Information
- Founded
- SGU 1995
- FLGT 2011
- Country
- SGU United States
- FLGT United States
- Employees
- SGU N/A
- FLGT N/A
- Industry
- SGU Other Specialty Stores
- FLGT Medical Specialities
- Sector
- SGU Consumer Discretionary
- FLGT Health Care
- Exchange
- SGU Nasdaq
- FLGT Nasdaq
- Market Cap
- SGU 445.9M
- FLGT 584.9M
- IPO Year
- SGU 1995
- FLGT 2016
- Fundamental
- Price
- SGU $12.60
- FLGT $18.56
- Analyst Decision
- SGU
- FLGT Buy
- Analyst Count
- SGU 0
- FLGT 2
- Target Price
- SGU N/A
- FLGT $24.00
- AVG Volume (30 Days)
- SGU 30.8K
- FLGT 376.2K
- Earning Date
- SGU 05-07-2025
- FLGT 05-02-2025
- Dividend Yield
- SGU 5.87%
- FLGT N/A
- EPS Growth
- SGU 91.90
- FLGT N/A
- EPS
- SGU 1.69
- FLGT N/A
- Revenue
- SGU $1,803,079,000.00
- FLGT $292,448,000.00
- Revenue This Year
- SGU N/A
- FLGT $11.70
- Revenue Next Year
- SGU N/A
- FLGT $9.90
- P/E Ratio
- SGU $7.47
- FLGT N/A
- Revenue Growth
- SGU 2.38
- FLGT 1.71
- 52 Week Low
- SGU $9.64
- FLGT $14.57
- 52 Week High
- SGU $13.75
- FLGT $25.11
- Technical
- Relative Strength Index (RSI)
- SGU 49.16
- FLGT 52.06
- Support Level
- SGU $12.03
- FLGT $18.42
- Resistance Level
- SGU $12.53
- FLGT $20.94
- Average True Range (ATR)
- SGU 0.47
- FLGT 0.81
- MACD
- SGU 0.02
- FLGT -0.02
- Stochastic Oscillator
- SGU 53.01
- FLGT 39.29
About SGU Star Group L.P.
Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. The company offers heating oil and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.